January 21, 2025
 
 

Small Stocks, Big Money™

Weekly Newsletter
REDCHIP.COM
 
 
Venu Holding Corporation Secures 46 Acres for $300M Sunset Amphitheater in McKinney, TX
 
Venu Holding Corporation (NYSE American: VENU) has closed on the property for its highly anticipated 20,000-seat Sunset Amphitheater in McKinney, TX. The $300M ultra-luxury venue will feature revolutionary amenities like Fire Pit Suites and the exclusive Aikman Club, powered by NFL legend Troy Aikman’s EIGHT Elite Light Beer. Located near Dallas-Fort Worth, the project marks a significant public-private partnership to boost McKinney’s status as a cultural and entertainment hub. Groundbreaking is slated for Spring 2025.
 
 
 
 
 
 
 
 
 
VSee Health Awarded Multi-Year, $6M First Year, Government Contract
 
VSee Health, Inc. (Nasdaq: VSEE) has been awarded a multi-year government contract, starting with $6M in the first year, to deliver its cutting-edge "Lego-like" Digital Health Building Blocks. The flexible platform will feature seamless EHR integration, advanced data visualization, and scalable capabilities to meet evolving needs. This contract positions VSee for growth, with renewal opportunities that could strengthen its role as a trusted partner in government health initiatives. Known for its innovative telehealth solutions, VSee is set to enhance healthcare delivery while addressing workforce shortages and physician burnout.
 
 
 
 
 
 
 
Gorilla Technology Expands Share Buyback Program Amid Market Volatility, Reaffirms Growth Strategy
 
Gorilla Technology Group Inc. (Nasdaq: GRRR) announced a $4M increase to its share buyback program, raising the total to $10M, signaling confidence in its long-term growth and addressing market misinterpretations. CEO Jay Chandan reassured shareholders of Gorilla’s robust financial position, $93M project backlog, and $2B pipeline of opportunities. Recent milestones include partnerships with NC Digy, Smart Cities, and AECOM for AI-driven urban innovation in Colombia and AI contracts in Taiwan. With $50M in expected cash inflows by Q1 2025, Gorilla is well-positioned for sustainable growth and remains committed to transparency and shareholder value.
 
 
 
 
 
 
 
 
 
 
Jupiter Neurosciences Targets NLRP3 Pathway in Upcoming JOTROL™ Trials
 
Jupiter Neurosciences, Inc. (Nasdaq: JUNS) will focus its upcoming JOTROL™ trials on the NLRP3 inflammasome, a key driver of neuroinflammation linked to CNS disorders, aging, and metabolic diseases. JOTROL’s patented delivery system overcomes resveratrol’s historical bioavailability challenges, enabling therapeutic plasma levels and blood-brain barrier penetration. This strategic shift supports Jupiter’s efforts to address unmet medical needs in Parkinson’s, Alzheimer’s, and obesity markets, leveraging a robust pipeline and expanding global partnerships.
 
 
 
 
 
 
 
Nova Minerals Identifies High-Grade Gold-Antimony Drill Targets at Estelle Project in Alaska
 
Nova Minerals Limited (Nasdaq: NVA) has pinpointed high-grade drill targets at the Stibium prospect within its 500km² Estelle Gold and Critical Minerals Project in Alaska. Soil and rock assays revealed gold grades up to 141 g/t and antimony grades as high as 60.5%, defining an 800m x 400m mineralized zone that remains open. Nova plans to launch drilling in 2025 to further define resources, with U.S. grant applications underway to support antimony production. Positioned in the prolific Tintina Gold Belt, the project aligns with growing demand for critical minerals like antimony, essential for U.S. economic and national security interests.
 
 
 
 
 
Recent News
 
 
 
 
 
 
 
 
 
 
Recent Research Coverage Updates
 
Company Rating Price Target Firm Report Date
OS Therapies (NYSE American: OSTX) Buy $20 D Boral Capital January 15, 2025
Venu Holding Corp. (NYSE American: VENU) Buy $15 ThinkEquity January 6, 2025
Nova Minerals (NASDAQ: NVA) Buy $25 ThinkEquity December 7, 2024
Alliance Entertainment (NASDAQ: AENT) Buy $8 ThinkEquity December 16, 2024
Calidi Biotherapeutics (NYSE American: CLDI) Buy $10 Ladenburg Thalmann November 21, 2024
ASP Isotopes (Nasdaq: ASPI) Buy $4.50 Cannacord Genuity October 4, 2024
LOBO EV (Nasdaq: LOBO) Buy $5 Zacks Small-Cap Research May 15, 2024
GreenPower Motor (Nasdaq: GP) Buy $1.65 Roth August 15, 2024
Enlivex Therapeutics (Nasdaq: ENLV) Buy $13 EF Hutton August 27, 2024
GreenPower Motor (Nasdaq: GP) Buy $3 RF Lafferty September 11, 2024
GreenPower Motor (Nasdaq: GP) Buy $5 Maxim July 2, 2024
GreenPower Motor (Nasdaq: GP) Hold n/a BTIG July 1, 2024
GreenPower Motor (Nasdaq: GP) Buy $3 Roth April 1, 2024
BioVie (Nasdaq: BIVI) Buy $3 ThinkEquity July 1, 2024
Calidi Biotherapeutics (NYSE American: CLDI) Buy $1 Ladenburg Thalman June 27, 2024
Calidi Biotherapeutics (NYSE American: CLDI) Buy $1 Rodman & Renshaw June 27, 2024
Calidi Biotherapeutics (NYSE American: CLDI) Buy $2 RW Baird May 14, 2024
Unusual Machines (NYSE American: UMAC) Buy n/a ThinkEquity June 17, 2024
Soligenix (Nasdaq: SNGX) n/a $4.15 Zacks Research June 14, 2024
Enlivex Therapeutics (Nasdaq: ENLV) Buy $6 HC Wainwright June 11, 2024
Sixty Degrees Pharma (Nasdaq: SXTP) Hold n/a HC Wainwright June 6, 2024
Sixty Degrees Pharma (Nasdaq: SXTP) Buy n/a Ascendiant May 21, 2024
American Resources (Nasdaq: AREC) Buy n/a HC Wainwright June 3, 2024
 
 
 
 
Small Stocks, Big Money™ Podcast
 
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
amazon music apple music spotify music
 
 
 
 
 
 
Upcoming Events
 
 
23
 
 
Jan 2025
 
NASDAQ: NXL - Nexalin Technology
4:15pm Eastern
 
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.
 
 
 
 
 
 
 
29
 
 
Jan 2025
 
NASDAQ: ASPI - ASP Isotopes
4:15pm Eastern
 
This exclusive event will provide investors with an opportunity to gain critical insights into ASP Isotopes' strategic initiatives and technological advancements.
 
 
 
 
 
 
 
Archived Events
 
 
8
 
 
Jan 2025
 
NASDAQ: LOBO - LOBO EV
4:15pm Eastern
 
LOBO EV, headquartered in Wuxi, China, is a pioneering OEM and ODM manufacturer and seller of electric vehicles (EVs), including e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles, tailored for various demographics, including mobility solutions for the elderly and disabled.
 
 
 
 
 
 
Quote of the Week
 
"Look for what's available, what is possible to do. That's the overriding consideration. There are a lot of things I would have liked to do, but didn't have the means."
— Dr. Phil Frost, Chairman of Opko Health
 
 
RedChip TV
 
 
 
 
RedChip Highlights bioAffinity Technologies (NASDAQ: BIAF) & Gorilla Technology Group (NASDAQ: GRRR)
 
 
 
 
 
 
 
Order "Small Stocks, Big Money™ Today!
 
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
 
 
 
 
 
 
 
Lesson of the Week
 
A look at the Random Walk theory and the unpredictability of short term price moves.